• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    2/19/25 4:02:37 PM ET
    $TRUP
    Medical Specialities
    Health Care
    Get the next $TRUP alert in real time by email
    trup-20250219
    false2024FY000137128500013712852025-02-192025-02-19

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): February 19, 2025
    TRUPANION, INC.
    (Exact name of registrant as specified in its charter)
    Delaware
    001-36537
    83-0480694
    (State or other jurisdiction of
    incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    6100 4th Avenue S, Suite 200
    Seattle, Washington 98108
    (Address of principal executive offices, including zip code)

    (855) 727 - 9079
    (Registrant's telephone number, including area code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common stock, $0.00001 par value per shareTRUPThe Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 2.02     Results of Operations and Financial Condition.
    On February 19, 2025 Trupanion, Inc. (the “Company”) issued a press release regarding the Company's financial results for the quarter ended December 31, 2024. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

    Item 9.01     Financial Statements and Exhibits.
    (d)Exhibits
    Exhibit No.Description
    99.1
    Press release regarding financial results issued by Trupanion, Inc. dated February 19, 2025
    104Cover Page Interactive Data File (formatted as Inline XBRL)




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    TRUPANION, INC.
    By:
    /s/ Fawwad Qureshi
    Name: Fawwad Qureshi
    Title: Chief Financial Officer
    Date: February 19, 2025


    Get the next $TRUP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TRUP

    DatePrice TargetRatingAnalyst
    1/23/2025$57.00Neutral → Overweight
    Piper Sandler
    7/19/2024Outperform
    William Blair
    5/16/2024$35.00 → $49.00Neutral → Buy
    BofA Securities
    5/8/2023$72.00 → $32.00Buy → Neutral
    BofA Securities
    9/21/2022$77.00Buy
    Jefferies
    8/4/2022$80.00 → $69.00Overweight → Neutral
    Piper Sandler
    2/24/2022$129.00 → $118.00Neutral → Buy
    B of A Securities
    12/8/2021$126.00 → $183.00Overweight
    Piper Sandler
    More analyst ratings

    $TRUP
    SEC Filings

    See more
    • SEC Form 10-Q filed by Trupanion Inc.

      10-Q - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 5:20:35 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 4:02:29 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by Trupanion Inc.

      DEFA14A - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 6:05:54 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Financials

    Live finance-specific insights

    See more
    • Trupanion Reports First Quarter 2025 Results

      SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e

      5/1/25 4:05:07 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

      SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 first quarter after the market closes on Thursday, May 1, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can acce

      4/17/25 4:30:00 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Reports Fourth Quarter & Full Year 2024 Results

      SEATTLE, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2024. "2024 was a milestone year for Trupanion. Strong execution drove 20% subscription revenue growth, the doubling of our subscription margin in Q4 from its quarterly low in 2023, and a record $39 million in free cash flow," said Margi Tooth, Chief Executive Officer and President of Trupanion. "As we look to 2025, our focus remains on sustainable, measured growth while enhancing the member experience and improving retention." Fourth Quarter 2024 Financial and

      2/19/25 4:05:00 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Top Animal Health Experts Address H5N1 Bird Flu in Trupanion Webinar

      SEATTLE, May 05, 2025 (GLOBE NEWSWIRE) -- Trupanion (NASDAQ:TRUP), the leading provider of medical insurance for dogs and cats, will host an upcoming webinar focused on the evolving state of bird flu (H5N1) and its impact on pets, pet parents, and the veterinary community. The complimentary one-hour RACE®-Approved CE webinar "Bird Flu: What We Know Now" will be available on-demand on petpublichealth.org/h5n1-update/ on Thursday, May 8th, at 11:00 AM PT / 2:00 PM ET. Hosted by Trupanion's Chief Veterinary/Product Officer, Dr. Steve Weinrauch, BVMS, MRCVS, the webinar features a panel of leading animal health experts, including: Gail Golab, PhD, DVM, MANZCVS (Animal Welfare), DACAW: Assoc

      5/5/25 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Reports First Quarter 2025 Results

      SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e

      5/1/25 4:05:07 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Publishes 2024 Annual Letter to Shareholders

      SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, has published its 2024 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here. About Trupanion: Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet parents with the hig

      4/30/25 5:15:00 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4) (Amendment)

      4/A - TRUPANION, INC. (0001371285) (Issuer)

      5/15/24 7:27:19 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      5/9/24 6:40:58 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Tooth Margaret sold $133,373 worth of shares (4,000 units at $33.34) and exercised 4,000 shares at a strike of $8.93 (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      4/23/25 4:19:30 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • CEO Tooth Margaret exercised 4,000 shares at a strike of $8.93 and sold $148,700 worth of shares (4,000 units at $37.17) (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      3/24/25 6:27:50 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Chief Administration Officer Mcgibney Brenna sold $164,926 worth of shares (5,000 units at $32.99), decreasing direct ownership by 57% to 3,738 units (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      3/11/25 4:20:06 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Trupanion Inc.

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      11/8/24 10:46:38 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      4/5/24 4:09:50 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      2/12/24 11:02:49 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Trupanion upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00

      1/23/25 7:55:01 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • William Blair initiated coverage on Trupanion

      William Blair initiated coverage of Trupanion with a rating of Outperform

      7/19/24 7:44:19 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion upgraded by BofA Securities with a new price target

      BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously

      5/16/24 7:37:42 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Leadership Updates

    Live Leadership Updates

    See more
    • Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System

      Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits  SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B

      8/14/24 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion's Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024

      SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he

      5/2/24 4:04:29 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Appoints Richard Enthoven, Global Entrepreneur and Founder of Hollard Insurance Company Australia, as Independent Board Director

      A global entrepreneur with decades of experience growing insurance businesses worldwide, including pet insurance brands in Australia and South AfricaEnthoven associated with Tarmac DLTFM LTD., holder of 8.6% of Trupanion outstanding shares SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) has appointed Richard Enthoven, Director at PetSure Australia and Hollard Holdings Australia, as an independent director to the Company's Board of Directors, effective today. Tarmac DLTFM LTD. ("Tarmac"), an Enthoven family investment entity, purchased shares of Trupanion in the open market between July and October of 2023, amounting to approximately 8.6% of Trupanion's outsta

      11/7/23 8:30:00 AM ET
      $TRUP
      Medical Specialities
      Health Care